Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
What To Expect From CBIZ’s (CBZ) Q4 Earnings
What To Expect From CBIZ’s (CBZ) Q4 Earnings
What To Expect From CBIZ’s (CBZ) Q4 Earnings
Jabin Bastian
Tue, February 24, 2026 at 12:04 PM GMT+9 2 min read
In this article:
CBZ
-5.04%
Financial services provider CBIZ (NYSE:CBZ) will be reporting earnings this Wednesday afternoon. Here’s what to look for.
CBIZ missed analysts’ revenue expectations last quarter, reporting revenues of $693.8 million, up 58.1% year on year. It was a satisfactory quarter for the company, with a beat of analysts’ EPS estimates but a significant miss of analysts’ revenue estimates.
Is CBIZ a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting CBIZ’s revenue to grow 25.6% year on year, slowing from the 40.5% increase it recorded in the same quarter last year.
CBIZ Total Revenue
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. CBIZ has missed Wall Street’s revenue estimates multiple times over the last two years.
Looking at CBIZ’s peers in the business process outsourcing & consulting segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Exponent delivered year-on-year revenue growth of 4.5%, beating analysts’ expectations by 1%, and Genpact reported revenues up 5.6%, topping estimates by 0.8%. Exponent traded up 12.7% following the results while Genpact was also up 7.1%.
Read our full analysis of Exponent’s results here and Genpact’s results here.
The outlook for 2025 remains clouded by potential trade policy changes and corporate tax discussions, which could impact business confidence and growth. While some of the business process outsourcing & consulting stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 8.9% on average over the last month. CBIZ is down 27.9% during the same time and is heading into earnings with an average analyst price target of $67.50 (compared to the current share price of $27.69).
When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.
條款 及 私隱政策
Privacy Dashboard
More Info